Traveler Brings Zika Virus Home to U.S.

Cases of the mosquito-borne infection are on the rise, with most reported in Brazil. The U.S. has confirmed at least two cases to date, including a recent importation into Texas.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Aedes aegypti, a Zika virus vectorWIKIMEDIA, MUHAMMAD MAHDI KARIMUntil recently, Zika virus had been a little-known tropical disease. The mosquito-borne pathogen causes a low-grade fever, rash, and some mild aches and pains. According to the US Centers for Disease Control and Prevention (CDC), only one in five people infected will even develop symptoms. The World Health Organization (WHO) reported Zika on U.S. ground last week (January 8) in Puerto Rico, and Texas health officials confirmed a case this week (January 11); a resident who had traveled outside the country imported the virus upon returning to the states.

The CDC recently announced a possible link between Zika cases in Brazil and a spike in infant microcephaly, which causes children to be born with abnormally small heads. “I wouldn’t use [the term] smoking gun, but what I would say is that these data provide the strongest evidence to date of a possible link between Zika virus and microcephaly and other congenital abnormalities,” Lyle Petersen, the director of the CDC’s division of vector-borne diseases, told STAT News.

Brazil reported 147 cases of microcephaly in 2014, but as of this week (January 12), that number has risen to 3,530, the country’s Ministry of Health reported. The first potential links between Zika virus infection and microcephaly in Brazil were reported last November. Women who have been infected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Karen Zusi

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours